Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,560,983
+$21,468,243 QoQ
Shares Held
2,525,293
+1107.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 639 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$400,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. HLN ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,560,983 | 2,525,293 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,092,740 | 209,065 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $9,396,972 | 913,214 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $634,009 | 66,458 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,290,369 | 405,517 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,657,302 | 200,642 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,389,440 | 517,013 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $560,328 | 66,865 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $400,000 | 50,000 | Put | Defined | 2023-02-14 | |
| 2022-12-31 | $1,085,736 | 135,717 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $279,573 | 45,907 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $304,500 | 50,000 | Put | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||